Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins
- PMID: 16291239
- DOI: 10.1016/S0076-6879(05)96024-2
Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins
Abstract
Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta and in other subcortical nuclei associated with a widespread occurrence of Lewy bodies. The causes of cell death in Parkinson's disease are still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative stress has been proposed. We have examined 3-morpholinosydnonimine (SIN-1)-induced apoptosis in control and metallothionein-overexpressing dopaminergic neurons, with a primary objective to determine the neuroprotective potential of metallothionein (MT) against peroxynitrite-induced neurodegeneration in PD. SIN-1 induced lipid peroxidation and triggered plasma membrane blebbing. In addition, it caused DNA fragmentation, alpha-synuclein induction, and intramitochondrial accumulation of metal ions (copper, iron, zinc, and calcium), and it enhanced the synthesis of 8-hydroxy-2-deoxyguanosine. Furthermore, it downregulated the expression of Bcl-2 and poly(adenosine diphosphate-ribose) polymerase, but upregulated the expression of caspase-3 and Bax in dopaminergic (SK-N-SH) neurons. SIN-1 induced apoptosis in aging mitochondrial genome knockout cells, alpha-synuclein-transfected cells, metallothionein double-knockout cells, and caspase-3-overexpressed dopaminergic neurons. SIN-1-induced changes were attenuated with selegiline or in metallothionein-transgenic striatal fetal stem cells. SIN-1-induced oxidation of dopamine (DA) to dihydroxyphenylacetaldehyde (DopaL) was attenuated in metallothionein-transgenic fetal stem cells and in cells transfected with a mitochondrial genome, and was enhanced in aging mitochondrial genome knockout cells, in metallothionein double-knockout cells, and caspase-3 gene-overexpressing dopaminergic neurons. Selegiline, melatonin, ubiquinone, and metallothionein suppressed SIN-1-induced downregulation of a mitochondrial genome and upregulation of caspase-3 as determined by reverse transcription polymerase chain reaction. These studies provide evidence that nitric oxide synthase activation and peroxynitrite ion overproduction may be involved in the etiopathogenesis of PD, and that metallothionein gene induction may provide neuroprotection.
Similar articles
-
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011. Brain Res Mol Brain Res. 2005. PMID: 15790531 Free PMC article. Review.
-
Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.Antioxid Redox Signal. 2003 Jun;5(3):251-64. doi: 10.1089/152308603322110832. Antioxid Redox Signal. 2003. PMID: 12880480
-
Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.Exp Biol Med (Maywood). 2006 Oct;231(9):1576-83. doi: 10.1177/153537020623100919. Exp Biol Med (Maywood). 2006. PMID: 17018883
-
Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.Brain Res. 2004 Apr 16;1005(1-2):67-76. doi: 10.1016/j.brainres.2004.01.054. Brain Res. 2004. PMID: 15044066
-
Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.Antioxid Redox Signal. 2003 Jun;5(3):319-35. doi: 10.1089/152308603322110896. Antioxid Redox Signal. 2003. PMID: 12880486 Review.
Cited by
-
Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss.J Neuroinflammation. 2018 May 25;15(1):161. doi: 10.1186/s12974-018-1194-5. J Neuroinflammation. 2018. PMID: 29801454 Free PMC article.
-
Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone.Exp Ther Med. 2015 Feb;9(2):553-558. doi: 10.3892/etm.2014.2099. Epub 2014 Dec 2. Exp Ther Med. 2015. PMID: 25574233 Free PMC article.
-
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson's Disease: What We Know so Far.Degener Neurol Neuromuscul Dis. 2023 Jan 26;13:1-13. doi: 10.2147/DNND.S361526. eCollection 2023. Degener Neurol Neuromuscul Dis. 2023. PMID: 36726995 Free PMC article. Review.
-
Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity.Neurochem Res. 2008 May;33(5):790-800. doi: 10.1007/s11064-007-9496-5. Epub 2007 Oct 17. Neurochem Res. 2008. PMID: 17940886
-
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011. Brain Res Mol Brain Res. 2005. PMID: 15790531 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials